BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology - Net Long/Short Value

ProShares Trust - ProShares Ultra Nasdaq Biotechnology
US ˙ NasdaqGM ˙ US74347R2141

BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Kaizen Financial Strategies
Tower Research Capital LLC (TRC)
Palumbo Wealth Management LLC
Ashton Thomas Private Wealth, LLC
Toth Financial Advisory Corp
Truvestments Capital Llc
Morgan Stanley
Franklin Resources Inc
MAI Capital Management
Simplex Trading, Llc
Wells Fargo & Company/mn
Citadel Advisors Llc
Capital Investment Advisors, LLC
Csenge Advisory Group
Pnc Financial Services Group, Inc.
RWM Asset Management, LLC
Axiom Investment Management LLC
UBS Group AG
Harel Insurance Investments & Financial Services Ltd.
Qube Research & Technologies Ltd
Whittier Trust Co
Susquehanna International Group, Llp
TD Waterhouse Canada Inc.
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista